SCHEMBL4923176

SCHEMBL4923176

CC(C)Nc1cccc(COc2c(Br)cc(C(=O)NCC(=O)O)cc2Br)c1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 4/20 0.40
THRB P10828 4/20 0.40
HPGD P15428 3/20 0.40
SMN1; SMN2 Q16637 4/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 2/20 0.39
GAA P10253 1/20 0.39
FFAR4 Q5NUL3 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
PDE5A O76074 1/20 0.36
PPARG P37231 1/20 0.36
EGLN1 Q9GZT9 1/20 0.36
ATM Q13315 1/20 0.36
GPR139 Q6DWJ6 3/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
PAX8 Q06710 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4927556 0.93 SMN1; SMN2 (0.39) THRATHRBHPGDSMN1; SMN2ALDH1A1
SCHEMBL5107222 0.91 SMN1; SMN2 (0.40) THRATHRBHPGDSMN1; SMN2ALDH1A1
SCHEMBL4926487 0.91 SMN1; SMN2 (0.41) THRATHRBHPGDSMN1; SMN2ALDH1A1
SCHEMBL4932776 0.90 HPGD (0.43) HPGDSMN1; SMN2ALDH1A1LMNAGAA
SCHEMBL5103210 0.89 HPGD (0.41) THRATHRBHPGDSMN1; SMN2ALDH1A1
SCHEMBL4933328 0.89 THRA (0.42) THRATHRBHPGDSMN1; SMN2ALDH1A1
SCHEMBL4354106 0.89 THRA (0.40) THRATHRBHPGDSMN1; SMN2ALDH1A1
SCHEMBL5103931 0.87 SMN1; SMN2 (0.42) THRATHRBHPGDSMN1; SMN2ALDH1A1
SCHEMBL4934628 0.87 SMN1; SMN2 (0.40) THRATHRBHPGDSMN1; SMN2ALDH1A1
SCHEMBL5109270 0.87 HPGD (0.38) THRATHRBHPGDSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA THRA 3/4885THRB 4/4885HPGD 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.